Your email has been successfully added to our mailing list.

×
0 0 -0.00363836824696801 -0.00363836824696801 0 -0.000882028665931624 -0.00110253583241449 -0.0047409040793825
Stock impact report

Better Buy: Celgene Corporation vs. Bristol-Myers Squibb [The Motley Fool]

CELGENE (CELG) 
Last celgene earnings: 10/31 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.celgene.com
Company Research Source: The Motley Fool
These drugmaker stocks have more in common than you might think. This stock is driven by a top-selling cancer therapy that's growing by leaps and bounds, but it's underperformed the market over the past five years. Which drugmaker am I referring to? Well, I could be talking about  Celgene Corporation   ( NASDAQ:CELG ) or   Bristol-Myers Squibb Company   ( NYSE:BMY ) .  The biotech stock has a lot more in common with the big pharma than you might think, but only one can come out on top in this head-to-head battle. Image source: Getty Images. The case for Celgene Investors don't need to look hard for reasons to like this biotech stock. Sales of Celgene's blood cancer therapy, Revlimid, finished the second quarter on pace to hit $9.8 billion this year after surging 21% compared to a year ago. Recently the company reported successful results from a drug it's developing in partnership with  Acceleron Pharma . Analysts could bump up their peak annual sales est Show less Read more
Impact Snapshot
Event Time:
CELG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CELG alerts
Opt-in for
CELG alerts

from News Quantified
Opt-in for
CELG alerts

from News Quantified